• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Life Technologies

Life Technologies

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Research and Markets: Cell Separation Technologies Market Report 2013-2019 - Immunology, Stem Cell, Cancer & Neuroscience Research

    Research and Markets: Cell Separation Technologies Market Report 2013-2019 - Immunology, Stem Cell, Cancer & Neuroscience Research

  2. Research and Markets: Global Biomarkers Markets Report 2014-2018: Cancer, Cardiac, Blood, Endocrine & Infectious Disease and Neurological Disease Markers

    Research and Markets: Global Biomarkers Markets Report 2014-2018: Cancer, Cardiac, Blood, Endocrine & Infectious Disease and Neurological Disease Markers

  3. Research and Markets: Global Prosthetic Heart Valves - Strategic Business Report 2014

    Research and Markets: Global Prosthetic Heart Valves - Strategic Business Report 2014

  4. 10 High-Conviction Purchases by the Ultimate Stock-Pickers

    Top managers continue to exercise a lot of patience as they look for buying opportunities in a U.S. equity market that has risen close to 40% since the start of 2013.

  5. Research and Markets: Global Life Science Reagents Market 2013-2019: Sigma Aldrich, Abbott Laboratories, Life Technologies , Bio-Rad Dominates the Market

    Research and Markets: Global Life Science Reagents Market 2013-2019: Sigma Aldrich, Abbott Laboratories, Life Technologies , Bio-Rad Dominates the Market

  6. Credit Outlook: Sector Updates and Top Bond Picks

    Get our sector-by-sector take on the bond market, plus our five best bond ideas.

  7. Top 10 Holdings of Our Best Performing Ultimate Stock-Pickers

    While a majority of our top fund managers are outperforming this year, three of them truly stand out from the rest given their ability to outperform the market over all time periods.

  8. Our Outlook for the Credit Markets

    Widening investment-grade credit spreads and rising interest rates lead to losses.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.